Eli Lilly & Co. (LLY) shares rose 0.3% premarket Wednesday, bouncing slightly after Tuesday's steep 6% plunge — the worst session for the stock in nearly four years.

Demand for weight-loss drugs surged throughout 2024, outpacing supply for most of the year. In December, Novo Holdings, an ...

Novo Nordisk announced positive trial results for its next-generation obesity drug, leading to a 7.13% surge in its share ...

The S&P 500 advanced 0.92% to 6,067.70, with technology shares seeing the biggest gains among sectors. The Technology Select ...

UnitedHealth Group CEO says complex US healthcare system needs to change Eli Lilly's stock tumbled 8% on Tuesday ... fails to impress in study; shares plunge Healthcare & Pharmaceuticalscategory ...

Chinese electric vehicle maker BYD plans to hire 20,000 employees in Zhengzhou in the first quarter, in areas including R&D ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Single-stock ETFs betting heavily on Nvidia’s blistering rally plunged overnight after tracking losses logged by the chip ...

Broadcom Inc. (NASDAQ: AVGO), a semiconductor, enterprise software, and security solutions provider, saw its stock plunge over 17% on Monday, January 27. This can be attributed to the ripples ...